Status: Recruiting
A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
The purpose of this study is to assess in real-life clinical practice, over a 24-month period, the effectiveness and safety and patient-reported outcomes (PROs) associated with standard of care (SOC) antimyeloma treatments in participants with previously treated relapsed and/or refractory multiple myeloma.
Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Janssen Pharmaceutica N.V., BelgiumUpdated: Jun 5, 2026Locations: 89
Eligibility criteria
For Period 1 and 2: Have a documented diagnosis of multiple myeloma according to... [+9]